文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症短疗程与长疗程抗生素治疗:一项全国性队列研究的事后分析

Short- versus long-course antibiotic therapy for sepsis: a post hoc analysis of the nationwide cohort study.
PubMed 文献 · J Intensive Care · 2022-10-29
一句话结论在日本全国性数据库中,脓毒症初始抗生素短疗程(≤7天)与28天死亡率显著降低相关(HR 0.94),但3天和7天再启动抗生素的比例更高。

本研究为基于日本2010年至2017年医保数据库的回顾性观察研究的事后分析,比较脓毒症患者初始抗生素短疗程(≤7天)与长疗程(≥8天)对28天死亡率的影响,采用倾向性评分匹配调整基线失衡。匹配后纳入448,146对患者,短疗程组28天死亡率显著更低(HR 0.94,95%CI 0.92-0.95,P<0.001),但3天、7天及住院期间再启动抗生素的比例显著更高(P<0.001)。短疗程组无抗生素天数更短(中位数21天[17,23] vs 17天[14,19],P<0.001),且医疗费用降低(系数-212美元,95%CI -223至-201,P<0.001)。亚组分析显示男性、社区获得性脓毒症、腹腔感染和心脏感染患者短疗程组28天死亡率显著降低,而非社区获得性脓毒症患者显著升高(HR 1.09,95%CI 1.06-1.12)。

要点

  • 倾向性评分匹配后448,146对脓毒症患者中,初始抗生素短疗程(≤7天)与28天死亡率显著降低相关(HR 0.94,95%CI 0.92-0.95,P<0.001)。
  • 短疗程组3天、7天及住院期间再启动抗生素的比例显著高于长疗程组(P<0.001)。
  • 短疗程组无抗生素天数中位数21天(IQR 17-23)显著长于长疗程组17天(IQR 14-19)(P<0.001)。
  • 短疗程与医疗费用降低相关(系数-212美元,95%CI -223至-201,P<0.001)。
  • 亚组分析:男性(HR 0.91,95%CI 0.89-0.93)、社区获得性脓毒症(HR 0.95,95%CI 0.93-0.98)、腹腔感染(HR 0.92,95%CI 0.88-0.97)、心脏感染(HR 0.74,95%CI 0.61-0.90)短疗程组28天死亡率显著降低;非社区获得性脓毒症患者短疗程组28天死亡率显著升高(HR 1.09,95%CI 1.06-1.12)。

适用人群与场景

  • 日本2010年至2017年医保数据库中的脓毒症患者,纳入回顾性观察研究的事后分析。
  • 按初始抗生素给药时长分为短疗程组(≤7天)和长疗程组(≥8天)。

研究设计与关键结果

  • 研究设计:基于日本全国性医保数据库(2010-2017年)的回顾性观察研究的事后分析,采用倾向性评分匹配,匹配后纳入448,146对患者。
  • 主要终点:28天死亡率短疗程组显著低于长疗程组(HR 0.94,95%CI 0.92-0.95,P<0.001)。
  • 次要终点:3天、7天及住院期间再启动抗生素的比例短疗程组显著更高(P<0.001);无抗生素天数短疗程组中位数21天(IQR 17-23) vs 长疗程组17天(IQR 14-19),长疗程组显著更短(P<0.001);短疗程与医疗费用降低相关(系数-212美元,95%CI -223至-201,P<0.001)。
  • 亚组分析:男性短疗程组28天死亡率HR 0.91(95%CI 0.89-0.93);社区获得性脓毒症HR 0.95(95%CI 0.93-0.98);腹腔感染HR 0.92(95%CI 0.88-0.97);心脏感染HR 0.74(95%CI 0.61-0.90);非社区获得性脓毒症短疗程组28天死亡率显著升高(HR 1.09,95%CI 1.06-1.12)。

证据类型、等级与局限

  • 证据类型:基于日本全国性医保数据库的回顾性观察研究的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,短疗程组28天死亡率显著更低,尽管短疗程组再启动抗生素的比例更高。
  • 亚组分析提示,非社区获得性脓毒症患者短疗程组28天死亡率显著升高(HR 1.09,95%CI 1.06-1.12)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The appropriate duration of antibiotic treatment in patients with bacterial sepsis remains unclear. The purpose of this study was to evaluate the association of a shorter course of antibiotics on 28-day mortality in comparison with a longer course using a national database in Japan.

METHODS: We conducted a post hoc analysis from the retrospective observational study of patients with sepsis using a Japanese claims database from 2010 to 2017. The patient dataset was divided into short-course (≤ 7 days) and long-course (≥ 8 days) groups according to the duration of initial antibiotic administration. Subsequently, propensity score matching was performed to adjust the baseline imbalance between the two groups. The primary outcome was 28-day mortality. The secondary outcomes were re-initiated antibiotics at 3 and 7 days, during hospitalization, administration period, antibiotic-free days, and medical cost.

RESULTS: After propensity score matching, 448,146 pairs were analyzed. The 28-day mortality was significantly lower in the short-course group (hazard ratio, 0.94; 95% CI, 0.92-0.95; P < 0.001), while the occurrence of re-initiated antibiotics at 3 and 7 days and during hospitalization were significantly higher in the short-course group (P < 0.001). Antibiotic-free days (median [IQR]) were significantly shorter in the long-course group (21 days [17 days, 23 days] vs. 17 days [14 days, 19 days], P < 0.001), and short-course administration contributed to a decrease in medical costs (coefficient $-212, 95% CI; - 223 to - 201, P < 0.001). Subgroup analyses showed a significant decrease in the 28-day mortality of the patients in the short-course group in patients of male sex (hazard ratio: 0.91, 95% CI; 0.89-0.93), community-onset sepsis (hazard ratio; 0.95, 95% CI; 0.93-0.98), abdominal infection (hazard ratio; 0.92, 95% CI; 0.88-0.97) and heart infection (hazard ratio; 0.74, 95% CI; 0.61-0.90), while a significant increase was observed in patients with non-community-onset sepsis (hazard ratio; 1.09, 95% CI; 1.06-1.12).

CONCLUSIONS: The 28-day mortality was significantly lower in the short-course group, even though there was a higher rate of re-initiated antibiotics in the short course.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Takahashi N, Imaeda T, Nakada TA, et al. Short- versus long-course antibiotic therapy for sepsis: a post hoc analysis of the nationwide cohort study. J Intensive Care. 2022. PMID: 36309710. doi:10.1186/s40560-022-00642-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。